The MarketWatch News Department was not involved in the creation of this content. --- Ruxoprubart (NM8074) met all clinical endpoints, offering a safe, differentiated treatment for Paroxysmal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback